This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.
Latest papers
Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma.
Clinical and experimental dermatology · 2026
Characteristics of Real-World Patients with Psoriasis Receiving Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Journal of psoriasis and psoriatic arthritis · 2026 · senior author
The risk and prevalence of hepatic diseases in psoriasis: A systematic review and meta-analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · senior author
Latest funding
- $50,000
Genomic instability and hypermutations in the pathogenesis of skin fibrosis in systemic scleroderma
CIHR · 2023 · Nominated PI
- $730,576
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
CIHR · 2023 · Principal investigator
- $100,000
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
CIHR · 2022 · Principal investigator
94 publications.
Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma.
Gulliver WP, Perlmutter JW, Gulliver SR, Tiplica GS, Lynde CW, Gniadecki R, Atkins H, Griffiths CEM, Lwin SM
Characteristics of Real-World Patients with Psoriasis Receiving Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Strober B, Augustin M, Tada Y, Parnell Lafferty K, Krol Y, Skobelev E, Ibrahim F, Fakharzadeh S, Gniadecki R
The risk and prevalence of hepatic diseases in psoriasis: A systematic review and meta-analysis.
Abdi P, Andrade LF, Emam S, Gniadecki R
Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes: A Randomized Controlled Trial.
Leung MSY, Li K, Zheng D, Bernier C, Kharel A, Dienes S, Abdi P, Yu A, Bai JQA, Maruschak-Love S, Turk T, Bosonea AM, Chow EY, Fiorillo L, Sanchez-Espino LF, Ting P, Gniadecki R, Dytoc M
Time-Driven Strategies for Inflammatory Skin Diseases: A Circadian Approach.
Farzad A, Moshkovich M, Litvinov IV, Gniadecki R, Netchiporouk E
Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report.
Ramadhan A, Troug A, Yacyshyn E, Gniadecki R
Should Calcium Supplementation be Abandoned in Patients With Calcinosis Cutis?
He R, Osman M, Owczarczyk-Saczonek A, Gniadecki R
Transcriptomic skin niches in systemic sclerosis underpin a role for mitochondrial dysfunction.
Wang J, Hennessey D, Iyer A, O'Keefe S, Khan L, Redmond D, Osman M, Gniadecki R
Pneumocystis jirovecii pneumonia prophylaxis in patients with chronic inflammatory skin diseases: Systematic review and meta-analysis.
Rahman S, Gniadecki R
Merkel cell carcinoma in a psoriasis patient on long-term ixekizumab therapy: A case report.
Malik SR, Salopek TG, Walker J, Gniadecki R
Genomic instability and hypermutations in the pathogenesis of skin fibrosis in systemic scleroderma
Principal investigators: Gniadecki, Robert
Keywords: Scleroderma
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
Principal investigators: Osman, Mohammed S; Gniadecki, Robert
Keywords: Autoimmunity; Fibrosis; Genomic Mutations; Mutations; Systemic Sclerosis
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
Principal investigators: Osman, Mohammed S; Gniadecki, Robert
Keywords: Autoimmunity; Fibrosis; Genomic Mutations; Mutations; Systemic Sclerosis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Dermatology and Skin Science
- Dermatology
- Department of Medicine
- Surgery
- Rheumatology
- Oncology
- Other
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Elena Netchiporouk
Dermatology
10 shared papers, latest 2026
Mohammed Osman
Medicine
10 shared papers, latest 2025
Ronald Vender
Medicine
7 shared papers, latest 2023
Elham Rahme
Medicine
4 shared papers, latest 2023
Jan Dutz
Dermatology and Skin Science
3 shared papers, latest 2023
Youwen Zhou
Dermatology and Skin Science
3 shared papers, latest 2023
Stephanie Keeling
Medicine
3 shared papers, latest 2024
Sunil Kalia
Dermatology and Skin Science
2 shared papers, latest 2023
Sebastien Hotte
Oncology
2 shared papers, latest 2023
Curtis Cooper
Department of Medicine
2 shared papers, latest 2023
Murray Baron
Rheumatology
2 shared papers, latest 2025
Carter Thorne
Faculty
1 shared papers, latest 2025
Rachael Manion
Faculty
1 shared papers, latest 2023
Shima Shahbaz
Dentistry
1 shared papers, latest 2025
Sabrina Hoa
Psychiatry
1 shared papers, latest 2025
Ross Tsuyuki
Medicine/Nephrology
1 shared papers, latest 2021
Deborah Assayag
Faculty
1 shared papers, latest 2023
Harold Atkins
Department of Medicine
1 shared papers, latest 2026
Andrew Mason
Medicine
1 shared papers, latest 2025
Lucie Germain
Chirurgie
1 shared papers, latest 2023
Anie Philip
Surgery
1 shared papers, latest 2023
An-Wen Chan
Faculty
1 shared papers, latest 2023
Sarvesh Logsetty
Surgery
1 shared papers, latest 2023
Shokrollah Elahi
Mike Petryk School of Dentistry
1 shared papers, latest 2025
Janet Pope
Department of Epidemiology and Biostatistics
1 shared papers, latest 2025
Julie Fradette
Surgery
1 shared papers, latest 2023
Ivan Litvinov
Dermatology
1 shared papers, latest 2023
Vincent Piguet
Faculty
1 shared papers, latest 2023
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.